glp-1 vs gip-1 Receptor Agonists – Peripheral Brain GLP-1 and GIP in Type

While most telehealth brands and compounding pharmacies do not disclose their revenue, industry juggernaut Hims said during a recent earnings call that it brought in about $225 million from GLP-1 drug sales last year

Finding a way to increase the biological half-life of GLP-1 or using GLP-1 analogs could be a step in the right direction to expand the treatment options for UC

By 2035 there will be 2bn obese individuals, and up to 4bn if one includes the overweight, a staggering 46% of the worlds population[2]

Greek yogurt, cottage cheese, deli turkey, tuna packets, rotisserie chicken, eggs, and shakes are often the easiest starting points

Furthermore, cost and access can be barriers